U.S. REITS Stock News

D-Wave Quantum Inc. has reported past fourth-quarter 2025 sales of US$2.75 million, up from US$2.31 million a year earlier, while its quarterly net loss narrowed to US$42.33 million from US$86.08 million, even as its full-year 2025 net loss widened to US$355.06 million on sales of US$24.59 million. Alongside these results, D-Wave highlighted new system sales, a large multi-year quantum computing service agreement, and the acquisition of Quantum Circuits, which together shift its story toward...

If you are wondering whether Xenon Pharmaceuticals at around US$43.79 is offering fair value or a potential mismatch between price and fundamentals, you are not alone. The stock has been choppy recently, with a 2.2% decline over the last 7 days, a 6.8% gain over 30 days, and returns of 21.6% over 1 year and 118.5% over 5 years. These moves can change how investors think about both opportunity and risk. These price moves sit against a backdrop of ongoing attention on the biopharma sector and...

Golar LNG Limited has reported its fourth-quarter 2025 results, posting quarterly revenue of US$132.81 million and net income of US$10.36 million, alongside full-year 2025 revenue of US$393.52 million and net income of US$65.68 million, while also declaring a total dividend of US$0.25 per share to be paid in March 2026. By combining strong full-year profitability with a completed US$117.32 million share buyback and a fresh dividend, Golar is reinforcing its transformation into a pure-play...

CVB Financial (CVBF) has come back into focus after director Kimberly Sheehy informed the company that she will not stand for reelection at the May 20, 2026 annual shareholder meeting. See our latest analysis for CVB Financial. At a share price of US$19.57, CVB Financial has had a modest year to date, with a 4.82% share price return and a 4.55% total shareholder return over 12 months. The 3 year total shareholder return of a 2.90% decline points to fading longer term momentum, which recent...

In February 2026, The TJX Companies, Inc. reported past fourth-quarter sales of US$17,743 million and net income of US$1,773 million, capping a fiscal year in which revenue exceeded US$60.37 billion and earnings per share from continuing operations reached US$4.87. Alongside these results, TJX outlined plans for further earnings growth in fiscal 2027 and authorized up to US$3.00 billion in share repurchases, signaling ongoing investment in both its store base and capital return...

ExlService Holdings (NasdaqGS:EXLS) announced a new partnership with Sonos and AWS to deploy agentic AI in IT service management. The collaboration focuses on using AI to streamline enterprise IT workflows and support functions. The news highlights a real world use case for AI in operations, beyond financial reporting or cost updates. For investors watching ExlService Holdings, this partnership comes as the stock trades around $31.93, with a 7 day return of 11.1% and a 5 year return of...

In February 2026, Valley National Bancorp declared quarterly cash dividends on its common and preferred shares and authorized a share repurchase program of up to 25,000,000 shares through April 27, 2028. These capital return decisions came as the bank continued to emphasize commercial banking growth and digital investments, even while regional lenders faced renewed scrutiny over inflation and credit risk. We’ll now examine how this combination of new buybacks and dividends could influence...

Valvoline overview and recent stock performance Valvoline (VVV) has drawn investor attention after recent trading, with the share price last closing at $37.50. Over the past month, the stock shows a 14.6% return and about 23% in the past 3 months. See our latest analysis for Valvoline. The recent 30 day share price return of 14.6% and 90 day gain of 22.7% suggest momentum has been building, even though the 1 year total shareholder return sits at 6.4%. If Valvoline’s move has you looking wider...

Event overview and recent share performance Sterling Infrastructure (STRL) is back on investors’ radar after a sharp single day move, with the stock down about 4% over the latest session and 9.6% over the past week. Those short term swings contrast with gains of 16% over the past month, 28.5% in the past 3 months and a 30.2% year to date return, prompting fresh attention on what is driving sentiment. See our latest analysis for Sterling Infrastructure. Short term, the recent 1 day share price...

If you are wondering whether Sea's current share price offers value for your money, this article will walk through what the market might be pricing in and how that lines up with the underlying business. Sea's share price closed at US$87.82, with returns of an 18% decline over 7 days, a 24.6% decline over 30 days, a 33.2% decline year to date and a 33.6% decline over the past year, while the 3 year return sits at 9.7% and the 5 year return at a 61.6% decline. These moves have put Sea back on...

Fresh coverage has pushed Toast (TOST) back into focus, spotlighting its role as a core integration layer across 156,000 restaurant locations that process US$51.5b in payments, alongside new enterprise wins and international expansion. See our latest analysis for Toast. Fresh coverage around Toast's role as a core restaurant platform arrives after a mixed stretch for the stock, with a 1-day share price return of 5.59% and 7-day share price return of 13.84%, set against a 30-day share price...

uniQure N.V. has reported full-year 2025 results, with revenue of US$16.1 million versus US$27.12 million a year earlier and a net loss of US$198.97 million versus US$239.56 million, alongside rising investor scrutiny over its Huntington’s disease program. Multiple securities class action lawsuits now allege that uniQure misrepresented aspects of its AMT-130 Huntington’s trial design and regulatory timelines, intensifying focus on how core pipeline disclosures align with future regulatory...

Why Immunome’s latest update caught investor attention Immunome (IMNM) has been in focus after management highlighted progress across its oncology pipeline, including top-line Phase 3 results for Varegacestat in desmoid tumors, alongside full year 2025 earnings that showed a smaller net loss. See our latest analysis for Immunome. Despite the clinical and earnings updates, Immunome’s share price has eased recently, with a 30 day share price return of a 12.51% decline, even though the 90 day...

General Mills (GIS) has come under closer investor scrutiny after cutting its full-year EPS guidance to a 16% to 20% decline, along with sharp drops in net income and operating income tied to affordability pressures. See our latest analysis for General Mills. Those guidance cuts and profit pressures have come alongside softer recent trading, with a 1-day share price return of 1.29% decline, 30-day share price return of 3.72% decline, and a 1-year total shareholder return of 23.51% loss,...

BigBear.ai Holdings (BBAI) just posted its FY 2025 numbers, closing out the year with Q4 revenue of US$27.3 million and a basic EPS loss of US$0.01, alongside a trailing twelve month basic EPS loss of US$0.82 on revenue of US$127.7 million. Over recent quarters the company has seen quarterly revenue move from US$43.8 million in Q4 2024 to US$27.3 million in Q4 2025. Basic EPS has ranged from a loss of US$0.58 in Q4 2024 to a small profit of US$0.01 in Q3 2025, before slipping back into a...

Nuvation Bio FY 2025 Earnings Snapshot Nuvation Bio (NUVB) has wrapped up FY 2025 with fourth quarter revenue of about US$41.9 million and a basic EPS loss of US$0.11, as the market weighs solid top line figures against continued bottom line pressure. The company has seen revenue move from US$5.7 million in Q4 2024 to US$41.9 million in Q4 2025, while quarterly basic EPS has ranged from a loss of US$0.15 in Q4 2024 to a loss of US$0.11 in Q4 2025 and a trailing twelve month basic EPS loss of...

Halozyme Therapeutics (NasdaqGS:HALO) has agreed to acquire Hypercon and several biotech startups, expanding its drug delivery and platform capabilities. The Hypercon deal extends Halozyme’s intellectual property coverage into the 2040s, supporting long term use of its core technologies. The company recently reported new ENHANZE-enabled collaborations and fresh global regulatory approvals for subcutaneous formulations using its platform. Halozyme Therapeutics, trading at $69.4, has recorded...

Without a clear headline event, DigitalBridge Group (DBRG) still attracts attention as a digital infrastructure focused asset manager, with recent returns and fundamentals giving investors several angles to reassess the stock’s current pricing. See our latest analysis for DigitalBridge Group. At a share price of US$15.46, DigitalBridge Group’s recent 90 day share price return of 56.8% contrasts with a 42.35% 1 year total shareholder return and a 5 year total shareholder return of 41.5%. This...

If you are wondering whether Progressive's share price still reflects its true worth after a strong multi year run, starting with the current valuation story can help you frame your next move. The stock last closed at US$213.35, with returns of 3.5% over the past week, 2.6% over the past month, 0.6% year to date, a 19.8% decline over the past year, and 61.2% and 164.7% over the past three and five years respectively. Recent headlines around Progressive have focused on the company as a major...

Wix.com (NasdaqGS:WIX) has launched a new Wix app inside ChatGPT. The integration lets users create and manage websites using conversational prompts. The collaboration connects OpenAI’s ChatGPT with Wix tools for website building and business operations. Wix.com, known for its website creation and business tools, is moving deeper into AI driven experiences through this new ChatGPT integration. By putting a Wix app directly inside ChatGPT, the company is tying its core website builder and...

Ubiquiti (UI) recently caught investors’ attention after being upgraded to a Zacks Rank #1. This move is tied to higher earnings estimates and renewed focus on how its current valuation stacks up. See our latest analysis for Ubiquiti. Ubiquiti’s share price has moved to US$762.35, with a 38.25% 1 month share price return and 35.24% 3 month share price return, while its 1 year total shareholder return of 137.14% points to strong longer term momentum around the recent earnings upgrade. If...

CME Group has recently expanded its regulated cryptocurrency futures suite to include Cardano, Chainlink, and Stellar, and announced plans for 24/7 crypto futures and options trading access starting May 29, pending regulatory approval. This push deeper into digital asset derivatives signals CME’s intent to become a core venue for institutional and retail crypto risk management under regulatory oversight. We’ll now examine how CME’s move to 24/7 crypto derivatives trading could reshape its...

Astera Labs (ALAB) is back in focus after its move into advanced optical interconnects, marked by the aiXscale Photonics acquisition, the establishment of an Israel Design Center, and a growing role in the UALink consortium with major hyperscalers. See our latest analysis for Astera Labs. Despite the recent flurry of AI infrastructure announcements, Astera Labs’ share price has pulled back. The 1-day share price return shows an 8.92% decline and the 30-day share price return shows a 27.10%...

AST SpaceMobile (NasdaqGS:ASTS) has signed a commercial agreement with TELUS to deliver space based cellular broadband to remote parts of Canada. The deal includes TELUS investing in AST SpaceMobile's satellite infrastructure and taking an equity stake in the company. AST SpaceMobile reports that it has moved from an R&D focus to commercial operations, with new satellite deployments and contracts across commercial and defense customers. For investors watching NasdaqGS:ASTS, this update...